Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma.

Saved in:
Bibliographic Details
Title: Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma.
Authors: Kaya NA; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore., Tai D; Division of Medical Oncology, National Cancer Centre Singapore, Singapore weiweizhai@ioz.ac.cn yeongps@imcb.a-star.edu.sg david.tai.w.m@singhealth.com.sg.; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.; Duke NUS Medical School, Singapore., Lim X; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Lim JQ; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore., Lau MC; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore.; Bioinformatics Institute (BII), Agency of Science Technology and Research, Singapore., Goh D; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Phua CZJ; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore., Wee FYT; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Joseph CR; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Lim JCT; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Neo ZW; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Ye J; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Cheung L; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Lee J; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.; Duke NUS Medical School, Singapore., Loke KSH; Duke NUS Medical School, Singapore.; Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore., Gogna A; Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore., Yao F; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore., Lee MY; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore., Shuen TWH; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Toh HC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Hilmer A; Institute of Pathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Koln, Cologne, Germany., Chan YS; Guangzhou Laboratory, Guangzhou International Bio Island, Guangzhou, Guangdong Province, China., Lim TK; Department of Anatomical Pathology, Singapore General Hospital, Singapore., Tam WL; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Choo SP; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Yeong J; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore weiweizhai@ioz.ac.cn yeongps@imcb.a-star.edu.sg david.tai.w.m@singhealth.com.sg.; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore., Zhai W; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore weiweizhai@ioz.ac.cn yeongps@imcb.a-star.edu.sg david.tai.w.m@singhealth.com.sg.; Key Laboratory of Zoological Systematics and Evolution, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Aug; Vol. 11 (8).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2023-007106